A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Clinical trial NCT05677893 · COMPLETED

Trial details

NCT number: NCT05677893
Sponsor: Oneness Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)

Start date: 2022-11-07
Primary completion: 2023-03-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.